A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

NCT07160634 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: SGT-003
DRUG: Placebo

Sponsor

Solid Biosciences Inc.